找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Immunotherapy for Head and Neck Cancer; Anthony T. C. Chan,Brigette B.Y. Ma Book 2023 The Editor(s) (if applicable) and The Author(s), und

[复制链接]
查看: 21002|回复: 41
发表于 2025-3-21 17:19:17 | 显示全部楼层 |阅读模式
书目名称Immunotherapy for Head and Neck Cancer
编辑Anthony T. C. Chan,Brigette B.Y. Ma
视频video
概述Crosses disciplines to provide peer reviewed chapters on a multi-disciplinary theme.Updates the field by comprehensively covering head and neck cancers.Presents novel therapeutics for immunotherapy in
丛书名称Cancer Immunotherapy
图书封面Titlebook: Immunotherapy for Head and Neck Cancer;  Anthony T. C. Chan,Brigette B.Y. Ma Book 2023 The Editor(s) (if applicable) and The Author(s), und
描述This book is a comprehensive summary of the literature on the scientific rationale and clinical development of immunotherapy for head and neck cancers..Head and neck cancer is a biologically diverse group of cancers that bear a common hallmark - evasion of host immune surveillance through innate or acquired mechanisms. The etiological association between the Human Papilloma virus (HPV) and some squamous head and neck cancers, the Epstein-Barr virus (EBV) and nasopharyngeal cancer has provided further impetus for evaluating immunotherapy in this group of cancers. The successful development of anti-programmed cell death protein-1 (PD-1)/ ligand (PD-L1) and CTLA-4 antibodies in solid tumours has gradually brought immunotherapy into mainstream oncological practice in recent years. Besides immune-checkpoint proteins inhibitors, other forms of immunotherapy such as vaccines, EBV or HPV-targeting therapies and cellular therapies are actively being investigated in clinical trials, either alone or in combination with other conventional treatments such as radiotherapy, chemotherapy and surgery. In clinical setting, the practicing oncologist need to be familiar with some unusual patterns of i
出版日期Book 2023
关键词Nasopharyngeal Cancer; Combinatorial approaches of immunotherapy and cytotoxic therapy; Immunotherapy;
版次1
doihttps://doi.org/10.1007/978-3-031-29223-1
isbn_softcover978-3-031-29225-5
isbn_ebook978-3-031-29223-1Series ISSN 2662-8384 Series E-ISSN 2662-8392
issn_series 2662-8384
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Immunotherapy for Head and Neck Cancer影响因子(影响力)




书目名称Immunotherapy for Head and Neck Cancer影响因子(影响力)学科排名




书目名称Immunotherapy for Head and Neck Cancer网络公开度




书目名称Immunotherapy for Head and Neck Cancer网络公开度学科排名




书目名称Immunotherapy for Head and Neck Cancer被引频次




书目名称Immunotherapy for Head and Neck Cancer被引频次学科排名




书目名称Immunotherapy for Head and Neck Cancer年度引用




书目名称Immunotherapy for Head and Neck Cancer年度引用学科排名




书目名称Immunotherapy for Head and Neck Cancer读者反馈




书目名称Immunotherapy for Head and Neck Cancer读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:40:25 | 显示全部楼层
Anthony T. C. Chan,Brigette B.Y. MaCrosses disciplines to provide peer reviewed chapters on a multi-disciplinary theme.Updates the field by comprehensively covering head and neck cancers.Presents novel therapeutics for immunotherapy in
发表于 2025-3-22 02:55:40 | 显示全部楼层
Cancer Immunotherapyhttp://image.papertrans.cn/i/image/462302.jpg
发表于 2025-3-22 05:24:35 | 显示全部楼层
978-3-031-29225-5The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
发表于 2025-3-22 10:44:56 | 显示全部楼层
发表于 2025-3-22 16:20:16 | 显示全部楼层
发表于 2025-3-22 20:39:59 | 显示全部楼层
Immunological Landscape of Head and Neck Cancer: Mechanisms of Immune Escape and the Tumor Microenv within the tumor microenvironment. Although dysfunctional antitumor immunity is particularly prominent in human papillomavirus (HPV)-negative head and neck cancers, HPV-driven tumors have also developed distinct mechanisms of immune escape.
发表于 2025-3-22 21:53:25 | 显示全部楼层
发表于 2025-3-23 04:13:49 | 显示全部楼层
Immunotherapy in Recurrent and Metastatic Nasopharyngeal Carcinoma, antibody is combined with platinum-based chemotherapy in the first-line treatment of R/M NPC have positioned immunotherapy as one of the mainstream therapeutic options for NPC. This review focused on the clinical impact of anti-PD1 antibodies on the palliative management of NPC.
发表于 2025-3-23 09:22:32 | 显示全部楼层
Translational and Clinical Approach to Combining Immunotherapy with Radiotherapy in the Treatment o immunotherapy to achieve optimal effect. We will review the mechanisms of immune evasion and resistance in head and neck squamous cell carcinoma, current preclinical evidence supporting the combination of radiation therapy with immunotherapy, and existing clinical data to elucidate those aforementioned questions.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-21 09:11
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表